218 related articles for article (PubMed ID: 26081558)
1. Molecular Docking Evaluation of Imidazole Analogues as Potent Candida albicans 14α-Demethylase Inhibitors.
Rani N; Kumar P; Singh R; Sharma A
Curr Comput Aided Drug Des; 2015; 11(1):8-20. PubMed ID: 26081558
[TBL] [Abstract][Full Text] [Related]
2. Molecular Modeling Studies of Halogenated Imidazoles against 14α- Demethylase from Candida Albicans for Treating Fungal Infections.
Rani N; Kumar P; Singh R
Infect Disord Drug Targets; 2020; 20(2):208-222. PubMed ID: 30499421
[TBL] [Abstract][Full Text] [Related]
3. Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy.
Jacob K S; Ganguly S; Kumar P; Poddar R; Kumar A
J Biomol Struct Dyn; 2017 May; 35(7):1446-1463. PubMed ID: 27142238
[TBL] [Abstract][Full Text] [Related]
4. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
Alvarez-Rueda N; Fleury A; Logé C; Pagniez F; Robert E; Morio F; Le Pape P
Med Mycol; 2016 Oct; 54(7):764-775. PubMed ID: 27143634
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Antifungal Activity Evaluation of New Thiazolin-4-ones as Potential Lanosterol 14α-Demethylase Inhibitors.
Stana A; Vodnar DC; Tamaian R; Pîrnău A; Vlase L; Ionuț I; Oniga O; Tiperciuc B
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106743
[TBL] [Abstract][Full Text] [Related]
6. In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent.
Singh A; Paliwal SK; Sharma M; Mittal A; Sharma S; Sharma JP
J Mol Graph Model; 2016 Jan; 63():1-7. PubMed ID: 26579619
[TBL] [Abstract][Full Text] [Related]
7. Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.
Friggeri L; Hargrove TY; Wawrzak Z; Blobaum AL; Rachakonda G; Lindsley CW; Villalta F; Nes WD; Botta M; Guengerich FP; Lepesheva GI
J Med Chem; 2018 Jul; 61(13):5679-5691. PubMed ID: 29894182
[TBL] [Abstract][Full Text] [Related]
8. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals.
Ji H; Zhang W; Zhou Y; Zhang M; Zhu J; Song Y; Lü J
J Med Chem; 2000 Jun; 43(13):2493-505. PubMed ID: 10891108
[TBL] [Abstract][Full Text] [Related]
9.
Khichi A; Jakhar R; Dahiya S; Arya J; Dangi M; Chhillar AK
J Biomol Struct Dyn; 2024 Jun; 42(9):4553-4566. PubMed ID: 37293950
[TBL] [Abstract][Full Text] [Related]
10. Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans.
Binjubair FA; Parker JE; Warrilow AG; Puri K; Braidley PJ; Tatar E; Kelly SL; Kelly DE; Simons C
ChemMedChem; 2020 Jul; 15(14):1294-1309. PubMed ID: 32459374
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate hitched imidazoles as agents for the disruption of fungal cell membrane.
Deswal D; Shukla P; Azad CS; Narula AK
J Mycol Med; 2020 Apr; 30(1):100910. PubMed ID: 31806380
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antifungal activity, and docking study of some new 1,2,4-triazole analogs.
Sangshetti JN; Lokwani DK; Sarkate AP; Shinde DB
Chem Biol Drug Des; 2011 Nov; 78(5):800-9. PubMed ID: 21752200
[TBL] [Abstract][Full Text] [Related]
13. Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design.
Monk BC; Sagatova AA; Hosseini P; Ruma YN; Wilson RK; Keniya MV
Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140206. PubMed ID: 30851431
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of benzotriazole derivatives as novel antifungal agents.
Shah JJ; Khedkar V; Coutinho EC; Mohanraj K
Bioorg Med Chem Lett; 2015 Sep; 25(17):3730-7. PubMed ID: 26117563
[TBL] [Abstract][Full Text] [Related]
15.
Singh G
Curr Drug Discov Technol; 2022; 19(6):e150622206033. PubMed ID: 35708080
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against
Marin V; Iturra A; Opazo A; Schmidt B; Heydenreich M; Ortiz L; Jiménez VA; Paz C
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32722158
[No Abstract] [Full Text] [Related]
17. Structural analyses of
Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
[TBL] [Abstract][Full Text] [Related]
18. Current and Future Prospective of a Versatile Moiety: Imidazole.
Rani N; Kumar P; Singh R; de Sousa DP; Sharma P
Curr Drug Targets; 2020; 21(11):1130-1155. PubMed ID: 32472996
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antifungal activity of some new imidazole and triazole derivatives.
Rezaei Z; Khabnadideh S; Zomorodian K; Pakshir K; Kashi G; Sanagoei N; Gholami S
Arch Pharm (Weinheim); 2011 Oct; 344(10):658-65. PubMed ID: 21984016
[TBL] [Abstract][Full Text] [Related]
20. Stepwise design, synthesis, and in vitro antifungal screening of (Z)-substituted-propenoic acid derivatives with potent broad-spectrum antifungal activity.
Khedr MA
Drug Des Devel Ther; 2015; 9():4501-13. PubMed ID: 26309398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
